Eric Daniels
Corporate Officer/Principal presso KIORA PHARMACEUTICALS, INC.
Patrimonio netto: 42 288 $ in data 30/04/2024
Profilo
Eric J.
Daniels is the founder of Okogen, Inc., Bayon Therapeutics, Inc. He is currently the Chief Development Officer at Kiora Pharmaceuticals, Inc. His former position was as the Chief Executive Officer at OccuRx Pty Ltd.
Dr. Daniels has an undergraduate degree from the University of California, Berkeley, a doctorate from the David Geffen School of Medicine, and an MBA from the Anderson School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/03/2024 | 88 100 ( 0.34% ) | 42 288 $ | 30/04/2024 |
Posizioni attive di Eric Daniels
| Società | Posizione | Inizio |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21/10/2021 |
Okogen, Inc.
 Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Fondatore | - |
| Bayon Therapeutics, Inc. | Fondatore | - |
Precedenti posizioni note di Eric Daniels
| Società | Posizione | Fine |
|---|---|---|
OccuRx Pty Ltd
 OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Amministratore Delegato | - |
Formazione di Eric Daniels
| University of California, Berkeley | Undergraduate Degree |
| David Geffen School of Medicine | Doctorate Degree |
| Anderson School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Okogen, Inc.
Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Commercial Services |
OccuRx Pty Ltd
OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Health Technology |
| Bayon Therapeutics, Inc. |
- Borsa valori
- Insiders
- Eric Daniels
